Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Japan Digital Genome Market Forecast 2021-2026

Published by Inkwood Research Product code 991381
Published Content info 109 Pages
Delivery time: 2-3 business days
Price
Back to Top
Japan Digital Genome Market Forecast 2021-2026
Published: March 1, 2021 Content info: 109 Pages
Description

KEY FINDINGS

The Japan digital genome market is anticipated to record a CAGR of 10.43%, across the forecast period. The augmenting healthcare system, the investments and initiatives undertaken by the governments, and the enhanced technological developments for gene editing, are anticipated to fuel the country's market growth. The base year considered for the studied market is 2020, while the forecast years from 2021 to 2026.

MARKET INSIGHTS

In February 2018, the government of Japan appointed 11 hospitals across the country to serve as core hospitals for cancer genomic medicine. Similarly, the government also delegated 100 facilities, as associated hospitals, to work in collaboration with core hospitals. As a result, the partnership would offer cancer genomic medicine under the national health insurance system. The genome project termed, Initiative on Rare and Undiagnosed Diseases (IRUD), was launched in 2015, aiming to diagnose patients with rare diseases in the country. Moreover, the IRUD receives annual grants ranging from ¥600 million to ¥700 million.

Japan is also willing to reinforce efforts to develop its technology for genome editing. In this regard, Japan's Economy, Trade, and Industry Ministry has allocated nearly $76,995,450, for the years 2016 to 2020. The investment would improve the development for treating stubborn diseases, such as, AIDS and hemophilia, and to modify crops and livestock genetically. Hence, these factors are set to propel the country's digital genome market growth during the forecast period.

COMPETITIVE INSIGHTS

Some of the key players operating in the country's market are, Bio-Rad Laboratories Inc, Abbott Laboratories, Illumina Inc, Thermo Fisher Scientific Inc, Becton, Dickinson and Company (BD), etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 36137

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. COUNTRY SNAPSHOT
  • 2.3. COUNTRY ANALYSIS
  • 2.4. KEY GROWTH ENABLERS
  • 2.5. KEY CHALLENGES

3. KEY ANALYTICS

  • 3.1. PORTER'S FIVE FORCES ANALYSIS
    • 3.1.1. THREAT OF NEW ENTRY
    • 3.1.2. THREAT OF SUBSTITUTION
    • 3.1.3. BUYER'S POWER
    • 3.1.4. SUPPLIER'S POWER
    • 3.1.5. COMPETITIVE RIVALRY
  • 3.2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET
  • 3.3. OPPORTUNITY MATRIX
  • 3.4. VENDOR LANDSCAPE
  • 3.5. KEY INVESTMENT INSIGHTS

4. MARKET BY PRODUCT

  • 4.1. SEQUENCING AND ANALYZER INSTRUMENTS
  • 4.2. DNA/RNA ANALYSIS
  • 4.3. SEQUENCING AND ANALYSIS SOFTWARE
  • 4.4. SEQUENCING CHIPS
  • 4.5. SAMPLE PREP INSTRUMENTS

5. MARKET BY APPLICATION

  • 5.1. DIAGNOSTICS
  • 5.2. DRUG DISCOVERY
  • 5.3. ACADEMIC RESEARCH
  • 5.4. PERSONALIZED MEDICINE
  • 5.5. AGRICULTURAL
  • 5.6. OTHER APPLICATIONS

6. MARKET BY END-USER

  • 6.1. DIAGNOSTICS AND FORENSIC LABS
  • 6.2. ACADEMIC RESEARCH INSTITUTES
  • 6.3. HOSPITALS
  • 6.4. OTHER END-USERS

7. COMPETITIVE LANDSCAPE

  • 7.1. KEY STRATEGIC DEVELOPMENTS
    • 7.1.1. MERGER & ACQUISITIONS
    • 7.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 7.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 7.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 7.2. COMPANY PROFILE
    • 7.2.1. ABBOTT LABORATORIES
    • 7.2.2. BECTON, DICKINSON AND COMPANY (BD)
    • 7.2.3. BIO-RAD LABORATORIES INC
    • 7.2.4. ILLUMINA INC
    • 7.2.5. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - DIGITAL GENOME
  • TABLE 2: JAPAN DIGITAL GENOME MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: JAPAN DIGITAL GENOME MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 4: JAPAN DIGITAL GENOME MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: JAPAN DIGITAL GENOME MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 6: JAPAN DIGITAL GENOME MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: JAPAN DIGITAL GENOME MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: JAPAN DIGITAL GENOME MARKET, BY PRODUCT, IN 2020
  • FIGURE 6: JAPAN DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2026 (IN $ MILLION)
  • FIGURE 7: JAPAN DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2026 (IN $ MILLION)
  • FIGURE 8: JAPAN DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2026 (IN $ MILLION)
  • FIGURE 9: JAPAN DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2026 (IN $ MILLION)
  • FIGURE 10: JAPAN DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2026 (IN $ MILLION)
  • FIGURE 11: JAPAN DIGITAL GENOME MARKET, BY APPLICATION, IN 2020
  • FIGURE 12: JAPAN DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2026 (IN $ MILLION)
  • FIGURE 13: JAPAN DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2026 (IN $ MILLION)
  • FIGURE 14: JAPAN DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2026 (IN $ MILLION)
  • FIGURE 15: JAPAN DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2026 (IN $ MILLION)
  • FIGURE 16: JAPAN DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2026 (IN $ MILLION)
  • FIGURE 17: JAPAN DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2026 (IN $ MILLION)
  • FIGURE 18: JAPAN DIGITAL GENOME MARKET, BY END-USER, IN 2020
  • FIGURE 19: JAPAN DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2026 (IN $ MILLION)
  • FIGURE 20: JAPAN DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2026 (IN $ MILLION)
  • FIGURE 21: JAPAN DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2026 (IN $ MILLION)
  • FIGURE 22: JAPAN DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2026 (IN $ MILLION)
Back to Top